BOD Pharma

Canimed About

BOD Pharma

The BOD Australia journey started in 2014, with a simple vision to innovate and create herbal-based healthcare products, backed by science and demonstrated evidence, bringing the best that both science and herbal medicine has to offer.

We applied evidence based scientific rigour and clinical trials to launch our first range of herbal-based products, which are currently ranged across pharmacies in Australia and online.

In late 2016, the world then opened up the opportunities to explore CBD and Medicinal Cannabis.

For Bod, CBD and Cannabis was a natural extension to our existing herbal-based healthcare products. With the unique and significant health benefits that CBD and Cannabis offers, our focus then shifted to harnessing these unique extracts and compounds for the health benefits of consumers and patients alike.

To deliver on this, we have partnered with some of the best in the business around the globe. From the cloned plants, grown under Good Agriculture Practices, harvested and extracted under EU GMP processes, we have meticulously formulated, crafted, bottled, packed and delivered our healthcare and medical products around the globe. Our products are currently being distributed in Australia and the UK.

Today, as a cannabis centric company and with a global focus, we are driven to innovate and transform the way we live and enjoy life.

Delivering premium, proven and trusted products for both the consumer markets and medical markets, we are leading the way in research and development, through collaborations with partners on clinical trial programs and are committed to supporting the healthcare professional on Cannabinoid applications with education, research and knowledge.

Medicabillis Sativa 50 COA




Community Interest Company 13392814